logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
L

Laurent Peyrin‐Biroulet

universite lorraine

137H-index
2.1KPaper Count
8.6WCitation Count
Published Papers 915
Publication Date
logo
Pulmonary diffusion abnormalities in patients with inflammatory bowel disease: A longitudinal study
errTherapeutic Advances in Gastroenterology
IF3.4
err2026-08-03
err0
PREAI
errHugo Maisonneuve; Benedicte Caron; Anne Guillaumot; Mathias Poussel; David Sorel; François Chabot; Bruno Ribeiro Baptista; Laurent Peyrin-Biroulet; Ari Chaouat; Simon Valentin
errShare
errSave
IOIBD: the International Organization for the Study of Inflammatory Bowel Disease
errTherapeutic Advances in Gastroenterology
IF3.4
err2026-08-02
err0
PREAI
errIris Dotan; Marla C. Dubinsky; Corey A. Siegel; James Lindsay; Dermot McGovern; Matthieu Allez; Pär Myrelid; James Lewis; Bruce E. Sands; Laurent Peyrin-Biroulet; Silvio Danese; Vineet Ahuja; Gilaad G. Kaplan; Marischka Konings; Richard Gearry; Siew C. Ng; Vipul Jairath; Fernando Magro; Mark S. Silverberg; Dan Turner; Maria T. Abreu; Ailsa Hart; Axel Dignass; David T. Rubin;
errShare
errSave
Global Roll-Out and Continued Multi-Site Validation of the Artificial Intelligence Histology Instrument for Qualitative Assessment of Histopathology in Ulcerative Colitis
errUnited European Gastroenterology Journal
IF6.7
err2026-07-30
err0
errOAAI
errLaurent Peyrin-Biroulet; Olga Kubassova; Jon Himoff; Christopher R. Weber; Shashi Adsul; Marcelo Freire; Bader E. Hussaini; Luc Biedermann; Viktor H. Koelzer; Brian Bressler; Wei Xiong; Jan H. Niess; Matthias S. Matter; Uri Kopylov; Iris Barshack; Chen Mayer; Fernando Magro; Fatima Carneiro; Nitsan Maharshak; Ariel Greenberg; David T. Rubin
errShare
errSave
Answer to Elbaz et al.
errJoint Bone Spine
IF4.3
err2026-07-06
err0
PREAI
errJean-Guillaume Letarouilly; Pauline Wils; Delphine Staumont-Sallé; Denis Jullien; Laurent Mortier; Laurent Peyrin-Biroulet; Christophe Richez; Marie Boileau; René-Marc Flipo
errShare
errSave
Clinical characteristics and treatment pathways of ulcerative colitis patients with isolated proctitis in Europe and the United States
errTherapeutic Advances in Gastroenterology
IF3.4
err2026-05-08
err0
PREAI
errAlessandro Armuzzi; Silvio Danese; Manuel Barreiro-de Acosta; Peter Hur; Lauren Bartolome; Karolina Wosik; Hannah Knight; Vanda Palace; Laurent Peyrin-Biroulet
errShare
errSave
Vedolizumab clinical decision support tool predicts clinically relevant targets in patients with Crohn’s disease
errTherapeutic Advances in Gastroenterology
IF3.4
err2026-05-04
err0
PREAI
errParambir S. Dulai; Giorgos Bamias; Vipul Jairath; Anthony Buisson; Marlies Meyer; Dirk Lindner; Christian Agboton; Laurent Peyrin-Biroulet
errShare
errSave
Time to rethink washout periods in inflammatory bowel disease clinical trials: an international Delphi consensus
errJournal of Crohn's and Colitis
IF8.7
err2026-05-01
err0
PREAI
errPauline Wils; Vipul Jairath; Bruce E Sands; Axel Dignass; Fernando Magro; David T Rubin; Iris Dotan; Walter Reinisch; Parambir Dulai; Richard Gearry; Christopher Ma; Millie Long; Alessandro Armuzzi; Taku Kobayashi; Dan Turner; Sophie Vieujean; Bram Verstockt; Ailsa Hart; Silvio Danese; Laurent Peyrin-Biroulet
errShare
errSave
Beyond class effects: moving towards drug-level precision in inflammatory bowel disease therapy
errNature Reviews Gastroenterology & Hepatology
IF51
err2026-04-08
err0
PREAI
errSailish Honap; Vipul Jairath; Fernando Magro; Silvio Danese; Laurent Peyrin-Biroulet
errShare
errSave
Building a Robust Investigator-Initiated Platform: The I-CARE Experience
errClinical Pharmacology & Therapeutics
IF5.5
err2026-02-15
err0
errOAAI
errJulien Kirchgesner; Laurent Beaugerie; Cédric Baumann; Filip Baert; Jean-François Rahier; Daniel Bergemalm; Fiorella Cañete; Bénédicte Caron; Marta Cossignani; Sandra Dias; Klaudia Farkas; Parker Girod; Idan Goren; Tom Holvoet; Susanne Krasz; Aditi Kumar; Peter Rimmer; Juliette Sheridan; Jessica Thut; Mathieu Uzzan; Nikos Viazis; Petra Weimers; Edyta Zagórowicz; Anne Buisson; Luisa Avedano; Helene Rousseau; Laurent Peyrin-Biroulet; Shaji Sebastian; I-CARE Collaborator Group
errShare
errSave
Impact of baseline Mayo endoscopic subscore on the efficacy of once-daily oral obefazimod in moderately to severely active ulcerative colitis: week 8 results from the two Phase 3 ABTECT induction trials
errJournal of Crohns & Colitis
IF8.7
err2026-01-01
err0
PREAI
errPeyrin-Biroulet, L.; Sands, B. E.; Armuzzi, A.; Cataldi, F.; Jacobstein, D.; Rabbat, C.; Shan, K.; Toeroek, H.; Nancey, S.; D'haens, G.; Laharie, D.; Dubinsky, M. C.
errShare
errSave
Benefit-risk profile of upadacitinib: exploratory post hoc analysis of phase 2b/3 studies in patients with moderately to severely active ulcerative colitis or Crohn's disease
errJournal of Crohns & Colitis
IF8.7
err2026-01-01
err1
PREAI
errVermeire, Severine; Colombel, Jean-Frederic; Danese, Silvio; Panaccione, Remo; Peyrin-Biroulet, Laurent; Beck, Kendall; Chaparro, Maria; Gisbert, Javier P.; Dubcenco, Elena; Klaff, Justin; Naling, Grace; Ford, Sharanya; Remple, Valencia; Joshi, Namita; Suravaram, Smitha; Duncan, Benjamin; Wang, Yibo; Wick-Urban, Bettina; Loftus Jr, Edward, V
errShare
errSave
Wash-out period in the transition from biologics to small molecules has no impact on safety in IBD: a retrospective cohort study
errJournal of Crohns & Colitis
IF8.7
err2026-01-01
err0
PREAI
errFanizzi, F.; D'Amico, F.; Zilli, A.; Solitano, V; Furfaro, F.; Parigi, T. L.; Allocca, M.; Peyrin-Biroulet, L.; Massimino, L.; Jairath, V; Danese, S.
errShare
errSave
Impact of obefazimod treatment on histologic and combined histologic-endoscopic outcomes in patients with moderately to severely active ulcerative colitis: results from the ABTECT-1 and ABTECT-2 Phase 3, double-blind, placebo-controlled induction trials
errJournal of Crohns & Colitis
IF8.7
err2026-01-01
err0
PREAI
errMagro, F.; Sands, B. E.; Danese, S.; Dubinsky, M. C.; Cataldi, F.; Jacobstein, D.; Rabbat, C.; Shan, K.; Harlacher, L.; Scaldaferri, F.; D'haens, G.; Biedermann, L.; Peyrin-Biroulet, L.
errShare
errSave
Impact of baseline disease extent on efficacy of obefazimod in patients with moderately to severely active ulcerative colitis: pooled results from ABTECT-1 and ABTECT-2 phase 3 trials
errJournal of Crohns & Colitis
IF8.7
err2026-01-01
err0
PREAI
errHeeren, S.; Dulai, P.; Neneman, B.; Bunganic, B.; Pumprla, J.; Cataldi, F.; Jacobstein, D.; Rabbat, C.; Shan, K.; Peyrin-Biroulet, L.
errShare
errSave
Integrated summary of safety of obefazimod in Phase 3 ABTECT induction trials
errJournal of Crohns & Colitis
IF8.7
err2026-01-01
err0
PREAI
errSeidler, U.; Danese, S.; Peyrin-Biroulet, L.; Dubinsky, M. C.; Atreya, R.; Armuzzi, A.; Cataldi, F.; Jacobstein, D.; Rabbat, C.; Shan, K.; Laharie, D.; Dulai, P.; Rubin, D. T.; Sands, B. E.
errShare
errSave
Building a healthcare data warehouse: considerations; opportunities; and challenges
errFrontiers in Digital Health
IF3.8
err2025-12-16
err0
errOAAI
errTamara Knezevic Ivanovski; Sailish Honap; Rade Matic; Srdjan Markovic; Laurent Peyrin-Biroulet
errShare
errSave
Bowel Urgency Improvement Correlates With Clinical, Biochemical, and Intestinal Ultrasound Improvements in Inflammatory Bowel Disease: A Cross Sectional Multicenter Study
errUNITED EUROPEAN GASTROENTEROLOGY JOURNAL
IF6.7
err2025-12-01
err0
errOAAI
errD'amico, Ferdinando; Nardone, Olga Maria; Bruno, Alessandro; Allocca, Mariangela; Zilli, Alessandra; Furfaro, Federica; Parigi, Tommaso Lorenzo; Solitano, Virginia; Ungaro, Federica; Faggiani, Ilaria; La Mantia, Alessia; Calabrese, Giulio; Fiorino, Gionata; Jairath, Vipul; Peyrin-Biroulet, Laurent; Massimino, Luca; Castiglione, Fabiana; Danese, Silvio
errShare
errSave
Efficacy and Safety of Obefazimod in Patients With Moderately to Severely Active Ulcerative Colitis: Results From Two, Phase 3, Randomised, Double-Blind, Placebo-Controlled, 8-Week Induction Trials (ABTECT-1 and 2)
errAMERICAN JOURNAL OF GASTROENTEROLOGY
IF7.6
err2025-12-01
err0
PREAI
errSands, Bruce E.; Danese, Silvio; Peyrin-Biroulet, Laurent; Dubinsky, Marla; Hisamatsu, Tadakazu; Tilg, Herbert; Atreya, Raja; Armuzzi, Alessandro; Treton, Xavier; Baert, Filip; Seidler, Ursula; Cataldi, Fabio; Jacobstein, Doug; Rabbat, Christopher J.; Shan, Kejia; Duvall, George Aaron; Siegmund, Britta; Dulai, Parambir S.; Rubin, David; Vermeire, Severine
errShare
errSave
Efficacy and safety of risankizumab in patients with moderately to severely active Crohn's disease: interim results from the SEQUENCE open-label extension study
errJOURNAL OF CROHNS & COLITIS
IF8.7
err2025-12-01
err0
errOAAI
errPeyrin-Biroulet, Laurent; Atreya, Raja; Danese, Silvio; Lindsay, James O.; Chapman, J. Casey; Anschutz, Toni; Huang, Xiu; Zambrano, Javier; van Haaren, Stijn; Joshi, Namita; Duan, W. Rachel; Cross, Raymond K.
errShare
errSave
Closing the Middle East and north Africa representation gap in clinical trials in inflammatory bowel disease
errThe Lancet Gastroenterology & Hepatology
IF38.6
err2025-11-25
err0
PREAI
errMohammad Shebab; Ahmed Al-Hindawi; Shane W Goodwin; Yuhong Yuan; Talat Bessissow; Laurent Peyrin-Biroulet; Vipul Jairath
errShare
errSave

Research Directions

No research directions
Co-authors
Cooperation Journals
W
William J. Sandborn
H-index: 199 · Papers: 2.1K
S
Stefan Schreiber
H-index: 192 · Papers: 1.9K
G
Grant W. Montgomery
H-index: 188 · Papers: 1.2K
C
Cisca Wijmenga
H-index: 169 · Papers: 996
S
Séverine Vermeire
H-index: 163 · Papers: 2.4K
View more